Kyle Knox

A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis

Chiea Chuen Khor, S. Jonathan Chapman, Fredrik Vannberg et al. · Nature Genetics · 2007 · 432 citations · Full text

Medical Microbiology, Invasive Pneumococcal Disease, Pulmonary Tuberculosis +9

Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial

Richard J. McManus, Jonathan Mant, Marloes Franssen et al. · The Lancet · 2018 · 405 citations · Full text

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher Butler, Richard Hobbs, Oghenekome Gbinigie et al. · The Lancet · 2022 · 391 citations · Full text

Long Covid, Treatment And Prevention, Covid-19 Pandemic +9

MBL genotype and risk of invasive pneumococcal disease: a case-control study

Suchismita Roy, Kyle Knox, Shelley Segal et al. · The Lancet · 2002 · 307 citations

Disease Susceptibility, Invasive Pneumococcal Disease, Mbl Genotype +10

Evolutionary dynamics of <i>Staphylococcus aureus</i> during progression from carriage to disease

Bernadette Young, Tanya Golubchik, Elizabeth M. Batty et al. · Proceedings of the National Academy of Sciences · 2012 · 283 citations · Full text

Microbial Pathogens, Molecular Epidemiology, Genetics +22